Dr Nusrat Sanghamitra is the founder and CEO of CyGenica. She is an accomplished scientist in the fields of biofunctional chemistry with over 20 years of experience. She is also the inventor of CyGenica’s core technology. She is a scientist turned entrepreneur, committed to make a difference in people's life by her scientific and personal endeavors. She started her research journey with a mission 'to find a better anticancer drug with fewer side effects'. She is a chemist by training with a fascination for biology. Her research has been well cited. After actively pursuing research at the institutes of International repute, she founded CyGenica to translate her ideas and research (at the interface of chemistry, biomaterials, cell biology and its applications in anticancer drug development) from bench to bedside, to make an impact in oncology and to make significant contribution to the global fight against cancer. She is the recipient of National Award in 2018 from the honorable President of India for developing a technology having commercialization potential. She is also the recipient of Leaders of Innovation Fellowship 2021 by Royal Academy of Engineering London.